Jun 22, 2020
LUNGevity and EGFR Resisters Collaborate on Lung Cancer Research Awards
May 18, 2020
Janssen Announces Phase 1 Results for Bispecific Antibody Amivantamab in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer Harboring Exon 20 Insertion Mutations
May 15, 2020
Ascentage Pharma to Present Six Abstracts at 2020 AACR Annual Meeting
May 07, 2020
Bridge Biotherapeutics Announces the IND Clearance of BBT-176, an EGFR TKI for NSCLC, in South Korea
Mar 19, 2020
Hoth Therapeutics Announces Positive Preclinical Data of WEG232 Treatment, Developed for Cancer Patients Suffering from Erlotinib-Induced Facial Dermatitis and Hair Loss
Mar 19, 2020
Hansoh Pharma's Ameile (Almonertinib) Receives Marketing Authorization in China for Second-Line Treatment for Patients With EGFR T790M-Mutation Non-Small Cell Lung Cancer
Feb 10, 2020
Kanazawa University Research: Combined Drug Treatment for Lung Cancer and Secondary Tumors
Jan 19, 2020
Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC
Jan 07, 2020
Hummingbird Bioscience Publishes Preclinical Data Demonstrating Efficacy of HMBD-001 in HER3 Driven Cancers
Dec 19, 2019
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-176, an EGFR TKI for NSCLC
Dec 13, 2019
CHMP Issues Positive Opinion to Expand CYRAMZA® (ramucirumab) Label to Include Results from RELAY Study in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Dec 05, 2019
Black Diamond Therapeutics Closes $85 Million Series C Financing
Nov 12, 2019
Clinical investigation for use of targeted chemotherapy for esophageal cancer
Nov 11, 2019
NuProbe Launches Ultrasensitive Sanger Assays for Oncology Therapy Selection and Recurrence Monitoring
Oct 29, 2019
Prime Therapeutics Study Finds Tagrisso® New First-line Lung Cancer Treatment Drives Ten-fold Use, $4 Million Cost Increase
Sep 26, 2019
Black Diamond Therapeutics to Present Preclinical Data on its Lead Product Candidate BDTX-189 at the European Society for Medical Oncology 2019
Sep 19, 2019
Black Diamond Therapeutics Names Christopher Roberts, Ph.D., as Chief Scientific Officer
Jul 24, 2019
First Patient Dosed in Sintilimab and Anti-VEGF Monoclonal Antibody IBI305 with Chemotherapy in Patients with EGFR-mutant Non-squamous NSCLC who have Progressed from Prior EGFR-TKI Treatment
Jul 01, 2019
The global EGFR inhibitors market at a CAGR of almost 9% during the forecast period
Jun 05, 2019
Targeted Cancer Therapeutics Market, 2025